Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Incyte Corporation
EIR
•Incyte Corporation•November 15, 2021

Incyte Corporation – FDA EIR, Nov 15, 2021

Record Details

The Food and Drug Administration (FDA) conducted a PDUFA surveillance inspection of Incyte Corporation, a corporate headquarters and sponsor of clinical trials, from November 8 to November 15, 2021. This inspection, conducted under Compliance Program 7348.810 for Sponsors and Contract Research Organizations, evaluated three clinical studies submitted to the FDA under a New Drug Application. The review encompassed various aspects of the clinical trials, including adherence to sponsor requirements for ClinicalTrials.gov listings, site training and monitoring, safety monitoring, investigational product control, and financial disclosures. The qualifications of clinical site monitors, Independent Data Monitoring Committee (IDMC) communications, and contracts with Contract Research Organizations (CROs) were also assessed. Crucially, the FDA inspection concluded without any findings. No Form FDA 483, indicating objectionable conditions, was issued, and no discussion items were raised with management at the closeout meeting. The inspection report noted positive comments regarding the company's efficient and organized provision of requested records. Furthermore, Incyte Corporation had successfully addressed all four discussion items from a previous FDA inspection conducted in April 2021. Overall, the company demonstrated adequate oversight of its clinical studies and monitoring activities, with no non-compliant sites or under-reporting of serious adverse events.

Company
Incyte Corporation
Inspection date
November 15, 2021
Product type
Drugs
Office
Philadelphia District Office
People
  • Michael Morrissey (recipient)
  • Gaafer El Mallah (company_representative)
  • Michele Houghton (company_representative)
  • Peter O’Neill (company_representative)
  • Judith Presser (company_representative)
View Company Profile

ID · 85295354-a4c4-4df8-bd2e-4d824812028a

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Incyte Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.